Document is current
Any future updates will be listed below
-
Authors
,
Mai, Elias K. https://orcid.org/0000-0002-6226-1252
Hielscher, Thomas
Bertsch, Uta
Schlenzka, Jana
Salwender, Hans J.
Munder, Markus
Gerecke, Christian
Dührsen, Ulrich
Brossart, Peter
Neben, Kai
Hillengass, Jens
Raab, Marc S.
Merz, Maximilian
Baertsch, Marc-Andrea
Jauch, Anna
Hose, Dirk
Martin, Hans
Lindemann, Hans-Walter
Blau, Igor W.
Scheid, Christof
Weisel, Katja C.
Goldschmidt, Hartmut
- License Information
-
More Information
Article History
Received: 5 April 2018
Revised: 8 May 2018
Accepted: 15 May 2018
First Online: 29 June 2018
Compliance with ethical standards
:
: EKM: Janssen: honoraria, travel grant; Takeda: honoraria, travel grant, advisory board; Celgene: travel grant; Onyx: travel grant; Munidpharma: travel grant. TH: nothing to disclose. UB: Novartis: travel grant. JS: nothing to disclose. HJS: Janssen-Cilag: research funding, honraria, travel grant; Celgene: research funding, honraria, travel grant. MMu: Janssen: advisory board, travel grant; BMS: advisory board, travel grant; Celgene: advisory board; Takeda: advisory board, travel grant; Amgen: advisory board, travel grant. CG: nothing to disclose. UD: nothing to disclose. PB: nothing to disclose. KN: Janssen: advisory board, travel grant; Takeda: advisory board; Celgene: advisory board, travel grant; Boehringer Ingelheim: advisory board; Roche: advisory board; BMS: advisory board; TEVA: advisory board. JH: Amgen: consultancy, honoraria, advisory board, travel grant; Celgene: consultancy, honoraria, advisory board, travel grant; Janssen: honoraria, advisory board, travel grant; Sanofi: research funding; Novartis: honoraria, advisory board, travel grant; BMS: honoraria, travel grant; Takeda: honoraria, travel grant. MSR: Amgen: honoraria, advisory board, research funding, travel grant; Novartis: honoraria, advisory board, research funding, travel grant; Celgene: honoraria, advisory board, travel grant; Janssen: honoraria, advisory board, travel grant; BMS: honoraria, advisory board, travel grant. MMe: Takeda: research funding; Janssen: travel grant; Celgene: travel grant. M-AB: Amgen: travel grant; BMS: travel grant; Janssen: travel grant; Novartis: travel grant, honoraria, research support; Takeda: honoraria. AJ: nothing to disclose. DH: Celgene: advisory board, research funding; Engmab: advisory board, research funding; Takeda: advisory board, travel grant. HM: nothing to disclose. H-WL: nothing to disclose. SC: nothing to disclose. IWB: nothing to disclose. CS: Amgen: honoraria, advisory board, travel grant; BMS: honoraria, advisory board, travel grant; Celgene: honoraria, advisory board, travel grant; Janssen: honoraria, advisory board, travel grant; Novartis: honoraria, advisory board, travel grant; Takeda: honoraria, advisory board, travel grant. KCW: Amgen: honoraria, advisory board, research funding; BMS: honoraria, advisory board; Celgene: honoraria, advisory board, research funding; Janssen: honoraria, advisory board, research funding; Novartis: honoraria, advisory board; Takeda: honoraria, advisory board; Sanofi: research funding. HG: BMS: honoraria, advisory board, research funding, travel grant; Celgene: honoraria, advisory board, research funding, travel grant; Janssen-Cilag: honoraria, advisory board, research funding, travel grant; Novartis: honoraria, advisory board, research funding; Amgen: honoraria, advisory board, travel grant; Takeda: advisory board, travel grant; Chugai: advisory board, research funding.
